Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Kerala Ayurveda

Sector: Healthcare | Industry: Drugs & Pharma
R 38.40 -0.15  | -0.39% -48.77% - 40.53
BSE Price: Oct 17, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 17, 2019 38.40 -0.15 -0.39% 37.60 38.55 1,605 37.50 - 39.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 2,531 P/B: 2.91 NSE Code:
52-Week Range: R 37.00 - 85.00 Dividend Yield: 0.00% BSE Code: 530163
TTM EPS: R -0.08 Book Value: R 13.21 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Kerala Ayurveda -45.42 -19.83 -30.31 -48.77 -16.89 1.73 -2.33
S&P BSE Small Cap -12.19 0.46 -5.85 -9.51 -0.50 4.60 5.21
S&P BSE Healthcare -10.20 -2.68 -4.93 -14.60 -7.95 -1.47 10.83
Company's return has been calculated on basis of BSE's price.
As on Oct 17, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 11.46 10.61 12.28
Net Profit -12.37 -2.67 22.39
EPS -12.95 -3.27 26.86
Book Value -52.85 37.51 18.71
Average
Operating Margin 8.64 12.74 14.08
Net Margin 4.02 5.22 5.59
Return on Networth 43.39 314.89 188.93
Return on Investment 7.42 8.41 8.54
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 8.72 7.21 8.72
Operating Profit 255.07 -23.86 255.07
Net Profit 182.57 -1.10 182.57
EPS 124.67 -1.09 124.67
TTM
Revenue 1.80 3.23 1.80
Operating Profit -8.93 -49.11 -8.93
Net Profit -0.42 -48.60 -0.42
EPS -6.20 -103.66 -6.20
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Kerala Ayurveda 40.53 47.33 1.19 -0.18 43.39 2.91 -
Astrazeneca Pharma India 5,748.75 771.42 69.56 8.84 20.03 17.95 82.64
Eris Lifesciences 5,689.19 1,005.70 303.64 29.29 28.96 4.61 18.74
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 20, 2018 ECL Finance Ltd  Buy Market 998,990 70.00 699.29
Jun 11, 2018 ECL Finance Ltd  Buy Encumbrance Share 2,472,170 84.20 2,081.57
Fund Houses invested in the stock
Fund Mar-95 Sep-94 Sep-94 Jun-94 Mar-94
Taurus Mutual Fund 0.004 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Kerala Ayurveda Ltd.

Address: 7/415, Nedumbassery, P O Athani, Aluva, Kerala - 683585 | Phone: 0484 - 2476301 / 2476302 / 2476303 / 2476304 | Fax: 0484 - 2474376

Email: [email protected]

Website: www.keralaayurveda.biz

Registrar & Transfer Agent: Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

Address: II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai, II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar | Phone: 044-28140801 | Fax: 044-28142479

Email: [email protected]

Essential checks
Altman Z-Score
0.72
Piotroski F-Score
4
Modified C-Score
4
5-Years Price to Earnings
Not applicable
5-Years Price to Book
2.91
Earnings Yield
EBIT / Enterprise value
2.22%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,299.25 +4.57%
Caplin Point Laboratories R394.45 -2.30%
Eris Lifesciences R416.05 -0.22%
FDC R161.35 +0.62%
JB Chemicals & Pharma R359.25 +0.45%
Laurus Labs R310.25 -0.80%
Strides Pharma Science R353.85 +0.78%
Sun Pharma Adv. Research R130.70 +1.32%
Suven Life Sciences R264.80 +1.83%
Wockhardt R259.20 +1.29%
As on Oct 17, 16:00